A Multi-site Randomized Controlled Trial Comparing Regional and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in Infants
NCT00756600 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 643
Last updated 2020-04-29
Summary
The primary purpose of the GAS study is to determine whether different types of anesthesia (Regional versus General) given to 720 infants undergoing inguinal hernia repair results in equivalent neurodevelopmental outcomes. The study also aims to describe the incidence of apnea in the post-operative period after both regional and general anesthesia for inguinal hernia repair in infants. This study is important as it will provide the greatest evidence for safety or toxicity of general anesthesia for human infants.
Conditions
- Inguinal Hernia
Interventions
- DRUG
-
Regional Anesthesia
Up to 2.5 mg/kg bupivacaine administered by caudal or subarachnoid routes or both caudal and subarachnoid or subarachnoid and ilioinguinal nerve blockade. Single shot.
- DRUG
-
General Anesthesia
Sevoflurane for induction and maintenance of general anesthesia, dose up to 8% inspired for duration of procedure plus bupivacaine local anesthetic blockade (up to 2.5 mg/kg) administered via caudal or ilioinguinal nerve block.
Sponsors & Collaborators
-
Royal Children's Hospital
collaborator OTHER -
Royal Hospital for Sick Children
collaborator OTHER -
Murdoch Childrens Research Institute
collaborator OTHER -
Food and Drug Administration (FDA)
collaborator FED - lead OTHER
Principal Investigators
-
Andrew Davidson, MD · Royal Children's Hospital, Victoria, Australia
-
Mary Ellen McCann, MD · Children's Hospital Boston, United States of America
-
Neil Morton, MD · Royal Hospital for Sick Children, Glasgow, United Kingdom
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Max Age
- 60 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-23
- Primary Completion
- 2018-06-30
- Completion
- 2018-06-30
- FDA Drug
- Yes
Countries
- United States
- Australia
- Canada
- Italy
- Netherlands
- New Zealand
- United Kingdom
Study Locations
More Related Trials
-
A RCT Study of ERAS in Infants With Choledochal Cyst
NCT05770739 ·Status: UNKNOWN ·Phase: NA
-
Nasal vs. Oral Intubation for Neonates Requiring Cardiac Surgery
NCT05378685 ·Status: UNKNOWN ·Phase: NA
-
Motor Development of Children That Have Surgery as Newborns for Complex Congenital Heart Disease
NCT02781545 ·Status: COMPLETED
-
International Fetal Anesthesia Database
NCT02591745 ·Status: ACTIVE_NOT_RECRUITING
-
Routine Or Selective Application of a Face Mask for Preterm Infants at Birth: the ROSA Trial
NCT04500353 ·Status: COMPLETED ·Phase: NA
-
Nitric Oxide During Cardiopulmonary Bypass in Neonates to Reduce Risk of Acute Kidney Injury
NCT04259684 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Neurodevelopmental Outcomes and Growth in Infants With Congenital Gastrointestinal Anomalies Requiring Neonatal Surgery
NCT04575649 ·Status: UNKNOWN
-
Evaluating Decisional Regret Among Mothers
NCT04074525 ·Status: COMPLETED
-
Effects of Flow Magnitude on Cardiorespiratory Stability During Nasal High Flow Therapy in Preterm Infants
NCT05908227 ·Status: RECRUITING ·Phase: NA
-
Open or Keyhole Surgery Through the Chest for Newborn Babies: Effect on Blood Gases
NCT01467245 ·Status: COMPLETED ·Phase: NA
-
Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room
NCT05031650 ·Status: COMPLETED ·Phase: NA
-
Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants
NCT01721629 ·Status: COMPLETED ·Phase: NA
-
Balanced Anesthesia for Intubation of Premature Infants
NCT00216944 ·Status: COMPLETED ·Phase: PHASE4
-
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
NCT03825835 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Risks and Benefits of Abdominal Massage Treatment in Neonatalogy in Premature Children
NCT03681782 ·Status: TERMINATED
-
Comparison of Different Oxygen Delivery Strategies During Resuscitation of Babies
NCT00356902 ·Status: COMPLETED ·Phase: NA
-
Delayed Umbilical Cord Clamping in Infants Less Than 32 Weeks
NCT00562536 ·Status: UNKNOWN ·Phase: NA
-
Infantile NO Replenishment as a New Therapeutic Possibility
NCT04914806 ·Status: RECRUITING
-
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
NCT05336890 ·Status: RECRUITING
-
Kangaroo Care and Premature Infant Sleep
NCT02473055 ·Status: COMPLETED ·Phase: NA
-
Oxygen Toxicity in the Resuscitation in Extremely Premature Infants
NCT00494702 ·Status: COMPLETED ·Phase: PHASE3
-
Generic Database of Moderate Preterm Infants
NCT01793116 ·Status: COMPLETED
-
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
NCT05213676 ·Status: RECRUITING ·Phase: PHASE4
-
The Newborn Project: Examining the Oxygenation of Brain Tissue During General Anesthesia
NCT03057587 ·Status: WITHDRAWN
-
Antenatal Steroids Effect on Mortality and Respiratory Outcomes in Preterm Infants
NCT04214795 ·Status: UNKNOWN